Add-on Study of Olmesartan Medoxomil in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Amlodipine 5 Mg Alone
Phase of Trial: Phase III
Latest Information Update: 02 Jan 2019
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Europe
- 20 Jun 2011 Mean 24-hour ambulatory BP results (stratified by baseline ABP) presented at the 21st European Meeting on Hypertension.
- 20 Jun 2011 Target blood pressure results presented at the 21st European Meeting on Hypertension.
- 13 Jun 2009 Results were presented at the 19th European Meeting on Hypertension.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History